Company intelligence / Profile preview
HLK Pharmacin
- Ownership
- Private
- Development stage
- Other
Overview
HLK Pharmacin is a global biotechnology company specializing in the development of value-added therapeutics through innovative formulation technologies. Headquartered in Shenzhen, China, with a key subsidiary in New Haven, Connecticut, the company focuses on the 505(b)(2) regulatory pathway to reformulate existing drugs for improved bioavailability, safety, and patient compliance. Its pipeline includes clinical-stage programs for anaphylaxis, psoriasis, and breast cancer, as well as preclinical candidates in oncology and psychiatry. HLK Pharmacin leverages proprietary platforms such as spray drying and peptide oral delivery to address unmet medical needs across multiple therapeutic areas.
- Therapeutic areas
- OncologyImmunologyDermatologyPsychiatry
- Modalities
- Small moleculePeptidessiRNAReformulated drugs
- Industry
- Biotech
Drug pipeline
13 assets12 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on HLK Pharmacin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HLK Pharmacin.